Cargando…

Pro-cognitive effect of 1MeTIQ on recognition memory in the ketamine model of schizophrenia in rats: the behavioural and neurochemical effects

RATIONALE: Schizophrenia is a mental illness which is characterised by positive and negative symptoms and by cognitive impairments. While the major prevailing hypothesis is that altered dopaminergic and/or glutamatergic transmission contributes to this disease, there is evidence that the noradrenerg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Białoń, Magdalena, Żarnowska, Marcelina, Antkiewicz-Michaluk, Lucyna, Wąsik, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239818/ https://www.ncbi.nlm.nih.gov/pubmed/32076746 http://dx.doi.org/10.1007/s00213-020-05484-1

Ejemplares similares

1MeTIQ and olanzapine, despite their neurochemical impact, did not ameliorate performance in fear conditioning and social interaction tests in an MK-801 rat model of schizophrenia
por: Białoń, Magdalena, et al.
Publicado: (2021)

Antidepressant-Like Effect of the Endogenous Neuroprotective Amine, 1MeTIQ in Clonidine-Induced Depression: Behavioral and Neurochemical Studies in Rats
por: Antkiewicz-Michaluk, Lucyna, et al.
Publicado: (2017)

Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
por: Wąsik, Agnieszka, et al.
Publicado: (2015)

S207. CHRONIC TREATMENT WITH 1METIQ INDUCES PRO-COGNITIVE EFFECT ON RECOGNITION MEMORY IN KETAMINE MODEL OF SCHIZOPHRENIA IN RATS
por: Białoń, Magdalena, et al.
Publicado: (2020)

The Impact of the Combined Administration of 1MeTIQ and MK-801 on Cell Viability, Oxidative Stress Markers, and Glutamate Release in the Rat Hippocampus
por: Wąsik, Agnieszka, et al.
Publicado: (2021)

Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study
por: Wąsik, Agnieszka, et al.
Publicado: (2017)

The Protective Effect of Repeated 1MeTIQ Administration on the Lactacystin-Induced Impairment of Dopamine Release and Decline in TH Level in the Rat Brain
por: Wąsik, Agnieszka, et al.
Publicado: (2018)

Chronic Salsolinol Administration Prevents the Behavioral and Neurochemical Effects of l-DOPA in Rats
por: Wąsik, Agnieszka, et al.
Publicado: (2015)

Antidepressant-like Effect of Tetrahydroisoquinoline Amines in the Animal Model of Depressive Disorder Induced by Repeated Administration of a Low Dose of Reserpine: Behavioral and Neurochemical Studies in the Rat
por: Antkiewicz-Michaluk, Lucyna, et al.
Publicado: (2014)

Repeated Transcranial Direct Current Stimulation Induces Behavioral, Metabolic and Neurochemical Effects in Rats on High-Calorie Diet
por: Ziomber, Agata, et al.
Publicado: (2018)

Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum
por: Wąsik, Agnieszka, et al.
Publicado: (2016)

1-Methyl-1,2,3,4-Tetrahydroisoquinoline, an Endogenous Amine with Unexpected Mechanism of Action: New Vistas of Therapeutic Application
por: Antkiewicz-Michaluk, Lucyna, et al.
Publicado: (2013)

1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an Endogenous Neurotoxic Compound, Disturbs the Behavioral and Biochemical Effects of l-DOPA: In Vivo and Ex Vivo Studies in the Rat
por: Wąsik, Agnieszka, et al.
Publicado: (2014)

Concentration-Dependent Opposite Effects of 1-Benzyl-1,2,3,4-tetrahydroisoquinoline on Markers of Apoptosis: In Vitro and Ex Vivo Studies
por: Wąsik, Agnieszka, et al.
Publicado: (2013)

Both Stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline Enantiomers Protect Striatal Terminals Against Rotenone-Induced Suppression of Dopamine Release
por: Antkiewicz-Michaluk, Lucyna, et al.
Publicado: (2010)

1-Methyl-1,2,3,4-tetrahydroisoquinoline, an Endogenous Neuroprotectant and MAO Inhibitor with Antidepressant-Like Properties in the Rat
por: Wąsik, Agnieszka, et al.
Publicado: (2013)

Changes in Monoaminergic Neurotransmission in an Animal Model of Osteoarthritis: The Role of Endocannabinoid Signaling
por: Mlost, Jakub, et al.
Publicado: (2018)

The adenosinergic system is involved in sensitization to morphine withdrawal signs in rats—neurochemical and molecular basis in dopaminergic system
por: Listos, Joanna, et al.
Publicado: (2016)

Salsolinol, an Endogenous Compound Triggers a Two-Phase Opposing Action in the Central Nervous System
por: Możdżeń, Edyta, et al.
Publicado: (2014)

Advantages and Limitations of Animal Schizophrenia Models
por: Białoń, Magdalena, et al.
Publicado: (2022)

Resilient Phenotype in Chronic Mild Stress Paradigm Is Associated with Altered Expression Levels of miR-18a-5p and Serotonin 5-HT(1a) Receptor in Dorsal Part of the Hippocampus
por: Zurawek, Dariusz, et al.
Publicado: (2019)

Neurochemical and Immunologic Components in Schizophrenia
por: Giller, Earl
Publicado: (1979)

Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT(6) partial agonist in rats
por: Jastrzębska-Więsek, Magdalena, et al.
Publicado: (2016)

Neurochemical Characterization of Brainstem Pro-Opiomelanocortin Cells
por: Georgescu, Teodora, et al.
Publicado: (2020)

Effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on the protective action of various antiepileptic drugs in the maximal electroshock-induced seizure model: a type II isobolographic analysis
por: Andres-Mach, Marta, et al.
Publicado: (2013)

Neuroanatomical, Neurochemical, and Neurodevelopmental Basis of Obsessive-Compulsive Symptoms in Schizophrenia
por: Venkatasubramanian, Ganesan, et al.
Publicado: (2009)

Behavioral and neurochemical effects of prenatal halothane
por: Bowman, Robert E., et al.
Publicado: (1977)

The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin
por: Reynolds, Gavin P.
Publicado: (2021)

Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use
por: Coulston, Carissa M., et al.
Publicado: (2011)

Facial emotion recognition in schizophrenia: neuropsychological and psychosocial correlates
por: Jaracz, Jan, et al.
Publicado: (2010)

Derivatives of a PARP Inhibitor TIQ-A through the Synthesis of 8-Alkoxythieno[2,3-c]isoquinolin-5(4H)-ones
por: Maksimainen, Mirko M., et al.
Publicado: (2020)

Neurochemical Effects of Chronic Administration of Calcitriol in Rats
por: Jiang, Pei, et al.
Publicado: (2014)

Immunomodulatory and pro-oncologic effects of ketamine and isoflurane anesthetics in a murine model
por: Abrahams, Dominique, et al.
Publicado: (2023)

Prolonged Ketamine Effects in Sp4 Hypomorphic Mice: Mimicking Phenotypes of Schizophrenia
por: Ji, Baohu, et al.
Publicado: (2013)

Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia
por: Kandratavicius, Ludmyla, et al.
Publicado: (2015)

PM363. The effect of Ketamine: Gunn rat as a Schizophrenia animal model
por: Hayashida, Maiko, et al.
Publicado: (2016)

Neurochemical and molecular mechanisms underlying the retrieval-extinction effect
por: Cahill, Emma N., et al.
Publicado: (2019)

Electrochemistry for neurochemical analysis
por: Ross, Ashley E., et al.
Publicado: (2021)

PM373. Behavioral and neurochemical abnormalities in heterozygous Reelin Orleans mutant mouse model of schizophrenia
por: Yamada, Kiyofumi, et al.
Publicado: (2016)

3.3 DISTURBANCES IN NEURAL OSCILLATIONS, GLUTAMATE, AND GABA: EFFECTS OF KETAMINE AND COMPARISON TO SCHIZOPHRENIA
por: Kegeles, Lawrence, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_75otldmck9h5h99jpum5levl7j